Vir Biotechnology, Inc.

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC VIR

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/13/2026

Shares

121,080

Value ($000)

730

Weight

0.0%

2020 Q2 - 2025 Q4 (23 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/13/2026	730	0.0%	121,080	12/31/2025
2025 Q3	11/14/2025	822	0.0%	143,938	9/30/2025
2025 Q2	8/14/2025	1,484	0.0%	294,383	6/30/2025
2025 Q1	5/19/2025	1,290	0.0%	199,063	3/31/2025
2024 Q4	2/14/2025	1,331	0.0%	181,325	12/31/2024
2024 Q3	11/14/2024	1,051	0.0%	140,371	9/30/2024
2024 Q2	8/14/2024	1,518	0.0%	170,559	6/30/2024
2024 Q1	5/15/2024	933	0.0%	92,059	3/31/2024
2023 Q4	2/14/2024	926	0.0%	92,059	12/31/2023
2023 Q3	11/13/2023	753	0.0%	80,414	9/30/2023
2023 Q2	8/11/2023	2,077	0.0%	89,243	6/30/2023
2023 Q1	5/15/2023	2,077	0.0%	89,243	3/31/2023
2022 Q4	2/14/2023	1,816	0.0%	71,745	12/31/2022
2022 Q3	11/14/2022	1,219	0.0%	63,231	9/30/2022
2022 Q2	8/12/2022	2,001	0.0%	78,566	6/30/2022
2022 Q1	5/16/2022	1,736	0.0%	67,480	3/31/2022
2021 Q4	2/14/2022	2,723	0.0%	65,042	12/31/2021
2021 Q3	11/15/2021	2,773	0.0%	63,719	9/30/2021
2021 Q2	8/16/2021	2,987	0.0%	63,170	6/30/2021
2021 Q1	5/14/2021	516	0.0%	10,059	3/31/2021
2020 Q4	3/1/2021	269	0.0%	10,059	12/31/2020
2020 Q3	11/13/2020	4,403	0.0%	128,258	9/30/2020
2020 Q2	8/14/2020	6,140	0.0%	149,857	6/30/2020